Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hoonmo L Koo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Review of Anti-Infective Therapy|June 15, 2006
Current and future developments in travelers' diarrhea therapyHoonmo L Koo, Herbert L DuPont
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2009
Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patientsHoonmo L Koo, Herbert L DuPont
Current Opinion in Gastroenterology|November 3, 2009
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesHoonmo L Koo, Herbert L DuPont
Expert Opinion on Investigational Drugs|June 5, 2010
Future novel therapeutic agents for Clostridium difficile infectionHoonmo L Koo, Kevin W Garey, Herbert L Dupont
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2007
Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosisHoonmo L Koo, Richard J Hamill, Roberto A Andrade
Therapeutics and Clinical Risk Management|November 10, 2009
The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrheaHoonmo L Koo, Herbert L Dupont, David B Huang
Clinical Medicine Insights. Gastroenterology|May 17, 2014
Rifaximin therapy of irritable bowel syndromeHoonmo L Koo, Saman Sabounchi, David B Huang, et al.
Discovery Medicine|July 31, 2010
Noroviruses: The leading cause of gastroenteritis worldwideHoonmo L Koo, Nadim Ajami, Robert L Atmar, et al.
Discovery Medicine|September 1, 2012
Clostridium difficile: an emerging pathogen in childrenNatalia Khalaf, Jonathan D Crews, Herbert L DuPont, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Antimotility agents for the treatment of Clostridium difficile diarrhea and colitisHoonmo L Koo, Diana C Koo, Daniel M Musher, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Anti-Infective Therapy|June 15, 2006
Current and future developments in travelers' diarrhea therapyHoonmo L Koo, Herbert L DuPont
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2009
Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patientsHoonmo L Koo, Herbert L DuPont
Current Opinion in Gastroenterology|November 3, 2009
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesHoonmo L Koo, Herbert L DuPont
Expert Opinion on Investigational Drugs|June 5, 2010
Future novel therapeutic agents for Clostridium difficile infectionHoonmo L Koo, Kevin W Garey, Herbert L Dupont
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2007
Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosisHoonmo L Koo, Richard J Hamill, Roberto A Andrade
Therapeutics and Clinical Risk Management|November 10, 2009
The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrheaHoonmo L Koo, Herbert L Dupont, David B Huang
Clinical Medicine Insights. Gastroenterology|May 17, 2014
Rifaximin therapy of irritable bowel syndromeHoonmo L Koo, Saman Sabounchi, David B Huang, et al.
Discovery Medicine|July 31, 2010
Noroviruses: The leading cause of gastroenteritis worldwideHoonmo L Koo, Nadim Ajami, Robert L Atmar, et al.
Discovery Medicine|September 1, 2012
Clostridium difficile: an emerging pathogen in childrenNatalia Khalaf, Jonathan D Crews, Herbert L DuPont, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Antimotility agents for the treatment of Clostridium difficile diarrhea and colitisHoonmo L Koo, Diana C Koo, Daniel M Musher, et al.
Pageof 3